Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

Radiopharm Theranostics (RADX)

Radiopharm Theranostics Ltd
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:RADX
DateTimeSourceHeadlineSymbolCompany
20/12/202413:00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:RADXRadiopharm Theranostics Ltd
20/12/202413:00GlobeNewswire Inc.RAD 202 Receives Approval to Start Phase 1 Therapeutic TrialNASDAQ:RADXRadiopharm Theranostics Ltd
19/12/202413:00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:RADXRadiopharm Theranostics Ltd
18/12/202413:28Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:RADXRadiopharm Theranostics Ltd
16/12/202405:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:RADXRadiopharm Theranostics Ltd
13/12/202414:45Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:RADXRadiopharm Theranostics Ltd
10/12/202411:23Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:RADXRadiopharm Theranostics Ltd
05/12/202421:02Edgar (US Regulatory)Form F-1 - Registration statement for certain foreign private issuersNASDAQ:RADXRadiopharm Theranostics Ltd
27/11/202413:00GlobeNewswire Inc.Radiopharm Achieves Nasdaq Listing of American Depositary SharesNASDAQ:RADXRadiopharm Theranostics Ltd
 Showing the most relevant articles for your search:NASDAQ:RADX